We are live on
!
Find out more
GA
Gagnon Advisors Portfolio holdings
AUM
$136M
1-Year Est. Return
21.55%
This Fund
S&P 500
This Quarter
Est. Return
+46.82%
1 Year Est. Return
+21.55%
3 Year Est. Return
+78.18%
5 Year Est. Return
+93.01%
10 Year Est. Return
+1,298.31%
AUM
$139M
AUM Growth
+$31.8M
(+30%)
Cap. Flow
-$8.92M
Cap. Flow
% of AUM
-6.42%
Top 10 Holdings %
Top 10 Hldgs %
63.74%
Holding
28
New
1
Increased
3
Reduced
3
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioLife Solutions
BLFS
|
+$1.64M |
| 2 |
Navigator Holdings
NVGS
|
+$1.24M |
| 3 |
PSIX
Power Solutions International
PSIX
|
+$454K |
| 4 |
Celcuity
CELC
|
+$64.5K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ameresco
AMRC
|
+$3.89M |
| 2 |
FLXN
Flexion Therapeutics, Inc.
FLXN
|
+$3.39M |
| 3 |
CareDx
CDNA
|
+$2.47M |
| 4 |
Onto Innovation
ONTO
|
+$2.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.34% |
| 2 | Healthcare | 21.97% |
| 3 | Industrials | 20.28% |
| 4 | Energy | 7.76% |
| 5 | Real Estate | 4.64% |
Similar funds
WF
MWA
SSCM
BDCMI
WA
LCM
NVCHI
GPWA
Gagnon Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Gagnon Advisors held 28 positions worth $139M, up 30% from $107M the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Gagnon Advisors withdrew a net $8.92M in Q2 2020, closing 2 positions and reducing 3 holdings. Its most notable exit was Flexion Therapeutics, Inc., an estimated $3.39M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 34% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Gagnon Advisors opened a new position in BioLife Solutions worth $1.95M.
- Gagnon Advisors's largest Q2 2020 buy was BioLife Solutions: 119,281 shares worth $1.95M.
- Gagnon Advisors added most to Navigator Holdings in Q2 2020, an estimated $1.24M increase.
- Gagnon Advisors's biggest Q2 2020 reduction was Ameresco, cutting an estimated $3.89M.
- Gagnon Advisors fully exited Flexion Therapeutics, Inc. in Q2 2020, selling an estimated $3.39M.
- Gagnon Advisors's ten largest holdings make up 64% of its $139M portfolio in Q2 2020.
- Gagnon Advisors opened 1 new position and closed 2 in Q2 2020.
- Gagnon Advisors's portfolio value rose 30% quarter-over-quarter to $139M.
Based on Gagnon Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.